Introduction course on genome editing through CRISPR/Cas Open for Technicians, PhD students and Postdocs.
Date: 28-29 June 2018, AMC
Interested in learning more about genome engineering through CRISPR/Cas and why this technology is offering new and exciting possibilities for cancer research? Sign up for the 2 day introduction course through:
contact@cancercenteramsterdam.nl
Course organizer: Dr. Daniël Warmerdam
John van der Oost, professor of Microbiology at the University of Wageningen, is one of the founders of CRISPR/Cas system. He has made important discoveries on how CRISPR/Cas contributes to bacterial immunity.
Identifying colorectal cancer vulnerabilities using a CRISPR-based kinome drop-out screen
Joyce Buikhuisen (AMC)
Full genome CRISPR screens reveal synthetic lethalities in the sister chromatid cohesion network
Klaas de Lint (VUmc)
Horizon: CRISPR screening tools and services
Ron Evers (Horizon)
Wednesday 18 July 2018
VUmc CCA 1.06 15:00 – 17:00
Hosted by Daniël Warmerdam
d.o.warmerdam@amc.uva.nl
Using a variant of Cas9 called Cpf1/Cas12a and the RNA targeting enzyme Cas13a researchers have recently published several methods (1, 2, 3, 4) that allow easy, rapid and highly sensitive detection of various viruses in blood. However, CRISPR diagnostics can be used for various applications, including genotyping and might also be used for early detection of cancer.